<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04410588</url>
  </required_header>
  <id_info>
    <org_study_id>marwawael</org_study_id>
    <nct_id>NCT04410588</nct_id>
  </id_info>
  <brief_title>Effect of Fentanyl With Topical Levobupivacaine With Nasal Packing in Endoscopic Nasal Surgery</brief_title>
  <acronym>fentanyl</acronym>
  <official_title>Effect of Fentanyl With Topical Levobupivacaine With Nasal Packing in Endoscopic Nasal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the Investigators aim to study the effect of fentanyl with topical levobupivacaine with nasal
      packing in endoscopic nasal surgery
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 20, 2020</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain by visual analoge score</measure>
    <time_frame>24 houres postoperative pain assessment</time_frame>
    <description>assessment of pain on removal of nasal packing after endoscopic nasal surgery by VAS score. The Visual Analogue Scale (VAS) (0, no discomfort and no pain; 10, a high level of discomfort and maximum pain)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Analgesia During Removal of Nasal Pack After Nasal Surgery</condition>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>saline for pain for nasal packing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>levobupivacaine for pain of nasal packing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fentanyl +levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fentanyle with levobupivacaine for pain of nasal packing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl + Topical Levobupivacaine</intervention_name>
    <description>in nasal packing</description>
    <arm_group_label>fentanyl +levobupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levobupivacaine</intervention_name>
    <description>in nasal packing</description>
    <arm_group_label>levobupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:1. All patients in the age of 18-60 year 2. ASA I-II 3. Undergoing
        elective nasal endoscopic surgery

        -

        Exclusion Criteria:

          1. Patients will also be excluded if any perioperative cardiovascular or respiratory
             event occurred which the anaesthetist with clinical responsibility for the patient
             thought would make the study intervention clinically unacceptable.

          2. unsatisfactory preoperative peripheral arterial oxygen saturation.

          3. Unsatisfactory preoperative hemoglobin level.

          4. Neurological or psychiatric disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marwa M Abdelrady</last_name>
    <phone>01006805857</phone>
    <email>marwarady-2012@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>wesam A Nashat</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wael</name>
      <address>
        <city>Assiut</city>
        <state>Asyut</state>
        <zip>11711</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wael m abdelrady</last_name>
      <phone>01006805857</phone>
      <email>marwarady-2012@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 20, 2020</study_first_submitted>
  <study_first_submitted_qc>May 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2020</study_first_posted>
  <last_update_submitted>May 29, 2020</last_update_submitted>
  <last_update_submitted_qc>May 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Marwa mahmoud Abd El Rady</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

